Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Exosome component 7 (EXOSC7) is a non-catalytic subunit of the RNA exosome complex, a multiprotein assembly responsible for the 3' to 5' degradation of a wide spectrum of RNA species in both the nucleus and cytoplasm of eukaryotic cells[2][3][5]. EXOSC7 contributes to the structural scaffold of the exosome, supporting the catalytic activities of associated ribonucleases and facilitating RNA substrate binding and presentation. The exosome complex participates in essential biological processes, such as maturation and quality control of rRNA, snRNA, and snoRNA, elimination of aberrant or non-coding transcripts, and overall regulation of mRNA stability and turnover. Mutations or altered expression of EXOSC7 have been implicated in rare neurodevelopmental disorders such as pontocerebellar hypoplasia and have prognostic significance in certain hematologic malignancies, notably mantle cell lymphoma[2][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Exosome component 7 (EXOSC7).